WebFeb 14, 2024 · At the time of writing, the ASX 200 Health Index (XHJ) is down 1%, while the benchmark ASX 200 is rising by 0.40%. Opthea Limited (ASX:OPT), a clinical stage biotech developing drugs for retinal diseases, has just presented data over the weekend at the 19th annual Angiogenesis, Exudation, and Degeneration 2024 Conference. The presentation, … WebApr 12, 2024 · Summary of all time highs, changes and price drops for Opthea; Historical stock prices; Current Share Price: AU$0.68: 52 Week High: AU$1.40: 52 Week Low: …
OPT share price and company information for ASX:OPT
WebFeb 16, 2024 · Read the latest Company Report General news from Opthea Limited (ASX:OPT) ... Article if they were interested to do so. It was not to “ramp up” the share price of its securities. Indeed, Opthea’s share price at close of trade on 14 February 2024 was $0.905 (i.e. closed down $0.030 from the closing price on 13 February 2024 (prior to the ... WebApr 14, 2024 · Opthea Limited ($ASX:OPT)'s share price experienced a 0.6% increase on Thursday, reaching a high of $3.84 before closing the trading day at $3.55. This marks fnsb tax records
OPT Competitors 2024 Opthea Alternatives - MarketBeat
WebJun 17, 2024 · The best performer on the All Ordinaries on Thursday has been the Opthea Ltd (ASX: OPT) share price. In morning trade, the biotechnology company’s shares are up … WebOpthea First Half 2024 Earnings: US$0.17 loss per share (vs US$0.11 loss in 1H 2024) Opthea ( ASX:OPT ) First Half 2024 Results Key Financial Results Net loss: US$77.1m (loss widened by 104% from 1H... WebAVERAGE : Opthea exhibits an implied growth ratio which is within a 15% range of the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. OPT calculation: 10% - (-$0.26 / $0.74) = 45.7% Implied Growth explained Price / Book 2.0 5.4 Industry Avg OPT fnsb shooting range